Bank of America’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,500
| Closed | -$4.22M | – | 8167 |
|
|
2025
Q3 | $4.22M | Hold |
7,500
| – | – | ﹤0.01% | 4178 |
|
|
2025
Q2 | $3.94M | Sell |
7,500
-9,700
| -56% | -$5.41M | ﹤0.01% | 4139 |
|
|
2025
Q1 | $10.9M | Sell |
17,200
-23,600
| -58% | -$16.2M | ﹤0.01% | 3047 |
|
|
2024
Q4 | $29.1M | Buy |
40,800
+2,300
| +6% | +$1.93M | ﹤0.01% | 1962 |
|
|
2024
Q3 | $40.5M | Sell |
38,500
-27,100
| -41% | -$30.2M | ﹤0.01% | 1750 |
|
|
2024
Q2 | $68.9M | Buy |
65,600
+39,300
| +149% | +$38.1M | 0.01% | 1237 |
|
|
2024
Q1 | $25.3M | Sell |
26,300
-2,700
| -9% | -$2.57M | ﹤0.01% | 2051 |
|
|
2023
Q4 | $25.5M | Sell |
29,000
-7,200
| -20% | -$5.93M | ﹤0.01% | 1913 |
|
|
2023
Q3 | $29.8M | Buy |
36,200
+4,700
| +15% | +$3.69M | ﹤0.01% | 1662 |
|
|
2023
Q2 | $22.6M | Sell |
31,500
-26,000
| -45% | -$20M | ﹤0.01% | 1906 |
|
|
2023
Q1 | $47.2M | Buy |
57,500
+23,500
| +69% | +$17.7M | ﹤0.01% | 1411 |
|
|
2022
Q4 | $24.5M | Sell |
34,000
-14,000
| -29% | -$10.3M | ﹤0.01% | 1843 |
|
|
2022
Q3 | $33.1M | Buy |
48,000
+27,500
| +134% | +$17.3M | ﹤0.01% | 1580 |
|
|
2022
Q2 | $12.1M | Hold |
20,500
| – | – | ﹤0.01% | 2492 |
|
|
2022
Q1 | $14.3M | Sell |
20,500
-34,500
| -63% | -$21.8M | ﹤0.01% | 2493 |
|
|
2021
Q4 | $34.7M | Buy |
55,000
+50,000
| +1,000% | +$30.7M | ﹤0.01% | 1708 |
|
|
2021
Q3 | $3.03M | Sell |
5,000
-40,400
| -89% | -$25.1M | ﹤0.01% | 4055 |
|
|
2021
Q2 | $25.4M | Sell |
45,400
-52,000
| -53% | -$26.3M | ﹤0.01% | 1925 |
|
|
2021
Q1 | $46.1M | Buy |
97,400
+65,000
| +201% | +$31.6M | 0.01% | 1359 |
|
|
2020
Q4 | $15.7M | Buy |
32,400
+27,400
| +548% | +$14.8M | ﹤0.01% | 2115 |
|
|
2020
Q3 | $2.8M | Hold |
5,000
| – | – | ﹤0.01% | 3415 |
|
|
2020
Q2 | $3.12M | Sell |
5,000
-10,000
| -67% | -$5.68M | ﹤0.01% | 3274 |
|
|
2020
Q1 | $7.32M | Sell |
15,000
-8,200
| -35% | -$3.38M | ﹤0.01% | 2316 |
|
|
2019
Q4 | $8.71M | Buy |
23,200
+16,000
| +222% | +$5.38M | ﹤0.01% | 2686 |
|
|
2019
Q3 | $2M | Hold |
7,200
| – | – | ﹤0.01% | 4054 |
|
|
2019
Q2 | $2.25M | Sell |
7,200
-12,100
| -63% | -$4.03M | ﹤0.01% | 3957 |
|
|
2019
Q1 | $7.92M | Sell |
19,300
-9,600
| -33% | -$3.95M | ﹤0.01% | 2711 |
|
|
2018
Q4 | $10.8M | Buy |
28,900
+7,200
| +33% | +$2.64M | ﹤0.01% | 2226 |
|
|
2018
Q3 | $8.77M | Sell |
21,700
-8,400
| -28% | -$3.2M | ﹤0.01% | 2614 |
|
|
2018
Q2 | $10.4M | Sell |
30,100
-43,600
| -59% | -$13.6M | ﹤0.01% | 2418 |
|
|
2018
Q1 | $25.4M | Buy |
73,700
+68,100
| +1,216% | +$23.7M | ﹤0.01% | 1578 |
|
|
2017
Q4 | $2.1M | Sell |
5,600
-6,600
| -54% | -$2.67M | ﹤0.01% | 3897 |
|
|
2017
Q3 | $5.46M | Buy |
+12,200
| New | +$5.81M | ﹤0.01% | 3106 |
|
|
2017
Q2 | – | Sell |
-46,100
| Closed | -$17.9M | – | 7128 |
|
|
2017
Q1 | $17.9M | Buy |
46,100
+42,900
| +1,341% | +$15.9M | ﹤0.01% | 1855 |
|
|
2016
Q4 | $1.18M | Sell |
3,200
-4,500
| -58% | -$1.71M | ﹤0.01% | 4210 |
|
|
2016
Q3 | $3.1M | Hold |
7,700
| – | – | ﹤0.01% | 3273 |
|
|
2016
Q2 | $2.69M | Hold |
7,700
| – | – | ﹤0.01% | 3385 |
|
|
2016
Q1 | $2.77M | Hold |
7,700
| – | – | ﹤0.01% | 3292 |
|
|
2015
Q4 | $4.18M | Hold |
7,700
| – | – | ﹤0.01% | 3128 |
|
|
2015
Q3 | $3.58M | Buy |
7,700
+4,500
| +141% | +$2.42M | ﹤0.01% | 3209 |
|
|
2015
Q2 | $1.63M | Buy |
+3,200
| New | +$1.56M | ﹤0.01% | 3668 |
|
|
2015
Q1 | – | Sell |
-38,900
| Closed | -$16M | – | 7459 |
|
|
2014
Q4 | $16M | Buy |
38,900
+3,300
| +9% | +$1.3M | 0.01% | 1553 |
|
|
2014
Q3 | $12.8M | Buy |
35,600
+12,700
| +55% | +$4.26M | ﹤0.01% | 1751 |
|
|
2014
Q2 | $6.47M | Buy |
22,900
+12,600
| +122% | +$3.73M | ﹤0.01% | 2311 |
|
|
2014
Q1 | $3.09M | Buy |
10,300
+6,000
| +140% | +$1.85M | ﹤0.01% | 2817 |
|
|
2013
Q4 | $1.18M | Sell |
4,300
-2,400
| -36% | -$690K | ﹤0.01% | 3884 |
|
|
2013
Q3 | $2.1M | Sell |
6,700
-2,400
| -26% | -$631K | ﹤0.01% | 3232 |
|
|
2013
Q2 | $2.05M | Buy |
+9,100
| New | +$2.12M | ﹤0.01% | 3186 |
|
Other funds holding REGN
VCM
N
Bank of America's REGN Position: Q1 2026 in Review
Bank of America increased its Regeneron Pharmaceuticals (REGN) stake by 2.8% in Q1 2026, buying an estimated $24.6M and bringing the position to 1,189,584 shares worth $919M. The position accounts for 0.07% of the portfolio, ranked #263.
Bank of America first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.04B in Q3 2024. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Bank of America held 1,189,584 shares of Regeneron Pharmaceuticals worth $919M as of Q1 2026.
- Bank of America bought 32,158 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $24.6M.
- Regeneron Pharmaceuticals made up 0.07% of Bank of America's portfolio in Q1 2026, its #263 holding.
- Bank of America first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Regeneron Pharmaceuticals position peaked at $1.04B in Q3 2024.
- 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.